Author: Jean-Christophe Galloux
Publisher: Université de Genève
ISBN: 3725566542
Category : Law
Languages : en
Pages : 163
Book Description
141p
La propriété intellectuelle dans l'industrie pharmaceutique / Intellectual property in the pharmaceutical industry
Author: Jean-Christophe Galloux
Publisher: Université de Genève
ISBN: 3725566542
Category : Law
Languages : en
Pages : 163
Book Description
141p
Publisher: Université de Genève
ISBN: 3725566542
Category : Law
Languages : en
Pages : 163
Book Description
141p
L'industrie pharmaceutique. Partie 1, Vue d'ensemble et perspectives
Author: Canada. Health Industries Branch
Publisher: La Direction générale
ISBN:
Category : Competition
Languages : en
Pages : 164
Book Description
This document is being published sequentially in 2 parts. An initial Overview and Prospect document profiles each sector in turn, examining trends and prospects. The follow-up Framework for Action draws upon consultations and inputs arising from industry-government collaboration, and identifies immediate to medium-term steps that both can take to improve sectoral competitiveness.
Publisher: La Direction générale
ISBN:
Category : Competition
Languages : en
Pages : 164
Book Description
This document is being published sequentially in 2 parts. An initial Overview and Prospect document profiles each sector in turn, examining trends and prospects. The follow-up Framework for Action draws upon consultations and inputs arising from industry-government collaboration, and identifies immediate to medium-term steps that both can take to improve sectoral competitiveness.
Sommaire du rapport de la Commission d'enquête sur l'industrie pharmaceutique
Author: Canada. Commission of Inquiry on the Pharmaceutical Industry
Publisher: The Commission
ISBN:
Category : Drugs
Languages : en
Pages : 56
Book Description
The Commission recommends some major modifications and extensions. The process leading to authorization for marketingshould become more rapid and more consultative. The terms onwhich compulsory licences are issued should ensure that thelicensing firms pay their share of the research and developmentand promotion expenditures from which they benefit. Royaltiesshould be distributed to the patent-holding firms in such a wayas to encourage research in Canada. Provincial plans shouldprovide consumers with greater knowledge about what drugs aresubstitutable and greater information on prices and should givethem incentives to seek out cheaper drugs.
Publisher: The Commission
ISBN:
Category : Drugs
Languages : en
Pages : 56
Book Description
The Commission recommends some major modifications and extensions. The process leading to authorization for marketingshould become more rapid and more consultative. The terms onwhich compulsory licences are issued should ensure that thelicensing firms pay their share of the research and developmentand promotion expenditures from which they benefit. Royaltiesshould be distributed to the patent-holding firms in such a wayas to encourage research in Canada. Provincial plans shouldprovide consumers with greater knowledge about what drugs aresubstitutable and greater information on prices and should givethem incentives to seek out cheaper drugs.
L'industrie Pharmaceutique en Mutation
Strength in Numbers
Author: Gunnar Trumbull
Publisher: Harvard University Press
ISBN: 0674071778
Category : Political Science
Languages : en
Pages : 261
Book Description
Many consumers feel powerless in the face of big industry’s interests. And the dominant view of economic regulators (influenced by Mancur Olson’s book The Logic of Collective Action, published in 1965) agrees with them. According to this view, diffuse interests like those of consumers are too difficult to organize and too weak to influence public policy, which is determined by the concentrated interests of industrial-strength players. Gunnar Trumbull makes the case that this view represents a misreading of both the historical record and the core logic of interest representation. Weak interests, he reveals, quite often emerge the victors in policy battles. Based on a cross-national set of empirical case studies focused on the consumer, retail, credit, pharmaceutical, and agricultural sectors, Strength in Numbers develops an alternative model of interest representation. The central challenge in influencing public policy, Trumbull argues, is not organization but legitimation. How do diffuse consumer groups convince legislators that their aims are more legitimate than industry’s? By forging unlikely alliances among the main actors in the process: activists, industry, and regulators. Trumbull explains how these “legitimacy coalitions” form around narratives that tie their agenda to a broader public interest, such as expanded access to goods or protection against harm. Successful legitimizing tactics explain why industry has been less powerful than is commonly thought in shaping agricultural policy in Europe and pharmaceutical policy in the United States. In both instances, weak interests carried the day.
Publisher: Harvard University Press
ISBN: 0674071778
Category : Political Science
Languages : en
Pages : 261
Book Description
Many consumers feel powerless in the face of big industry’s interests. And the dominant view of economic regulators (influenced by Mancur Olson’s book The Logic of Collective Action, published in 1965) agrees with them. According to this view, diffuse interests like those of consumers are too difficult to organize and too weak to influence public policy, which is determined by the concentrated interests of industrial-strength players. Gunnar Trumbull makes the case that this view represents a misreading of both the historical record and the core logic of interest representation. Weak interests, he reveals, quite often emerge the victors in policy battles. Based on a cross-national set of empirical case studies focused on the consumer, retail, credit, pharmaceutical, and agricultural sectors, Strength in Numbers develops an alternative model of interest representation. The central challenge in influencing public policy, Trumbull argues, is not organization but legitimation. How do diffuse consumer groups convince legislators that their aims are more legitimate than industry’s? By forging unlikely alliances among the main actors in the process: activists, industry, and regulators. Trumbull explains how these “legitimacy coalitions” form around narratives that tie their agenda to a broader public interest, such as expanded access to goods or protection against harm. Successful legitimizing tactics explain why industry has been less powerful than is commonly thought in shaping agricultural policy in Europe and pharmaceutical policy in the United States. In both instances, weak interests carried the day.
Drug Safety
Author: Michel Auriche
Publisher: Elsevier
ISBN: 1483140377
Category : Medical
Languages : en
Pages : 328
Book Description
Drug Safety
Publisher: Elsevier
ISBN: 1483140377
Category : Medical
Languages : en
Pages : 328
Book Description
Drug Safety
National Library of Medicine Current Catalog
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1106
Book Description
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1106
Book Description
International Pharmaceutical Services
Author: Richard N. Spivey
Publisher: Psychology Press
ISBN: 9780866569064
Category : Business & Economics
Languages : en
Pages : 686
Book Description
A comparative overview of the laws which govern pharmacy services in different countries, the organization of the medical community and health care delivery services, and the involvement of pharmacy practice within the health care delivery system. Annotation copyright Book News, Inc. Portland, Or.
Publisher: Psychology Press
ISBN: 9780866569064
Category : Business & Economics
Languages : en
Pages : 686
Book Description
A comparative overview of the laws which govern pharmacy services in different countries, the organization of the medical community and health care delivery services, and the involvement of pharmacy practice within the health care delivery system. Annotation copyright Book News, Inc. Portland, Or.
Current Catalog
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 656
Book Description
First multi-year cumulation covers six years: 1965-70.
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 656
Book Description
First multi-year cumulation covers six years: 1965-70.
Illicit Medicines in the Global South
Author: Mathieu Quet
Publisher: Routledge
ISBN: 1000463249
Category : Health & Fitness
Languages : en
Pages : 179
Book Description
This book investigates pharmaceutical regulation and the public health issue of fake or illicit medicines in developing countries. The book analyses the evolution of pharmaceutical capitalism, showing how the entanglement of market and health interests has come to shape global regulation. Drawing on extensive fieldwork in India, Kenya, and Europe, it demonstrates how large pharmaceutical companies have used the fight against fake medicines to serve their strategic interests and protect their monopolies, sometimes to the detriment of access to medicines in developing countries. The book investigates how the contemporary dynamics of pharmaceutical power in global markets have gone on to shape societies locally, resulting in more security-oriented policies. These processes highlight the key consequences of contemporary "logistical regimes" for access to health. Providing important insights on how the flows of commodities, persons, and knowledge shape contemporary access to medicines in the developing countries, this book will be of considerable interest to policy makers and regulators, and to scholars and students across sociology, science and technology studies, global health, and development studies.
Publisher: Routledge
ISBN: 1000463249
Category : Health & Fitness
Languages : en
Pages : 179
Book Description
This book investigates pharmaceutical regulation and the public health issue of fake or illicit medicines in developing countries. The book analyses the evolution of pharmaceutical capitalism, showing how the entanglement of market and health interests has come to shape global regulation. Drawing on extensive fieldwork in India, Kenya, and Europe, it demonstrates how large pharmaceutical companies have used the fight against fake medicines to serve their strategic interests and protect their monopolies, sometimes to the detriment of access to medicines in developing countries. The book investigates how the contemporary dynamics of pharmaceutical power in global markets have gone on to shape societies locally, resulting in more security-oriented policies. These processes highlight the key consequences of contemporary "logistical regimes" for access to health. Providing important insights on how the flows of commodities, persons, and knowledge shape contemporary access to medicines in the developing countries, this book will be of considerable interest to policy makers and regulators, and to scholars and students across sociology, science and technology studies, global health, and development studies.